TSLA Stock: Analysts Confirm Split Outlook as Tesla Surges 5% to Start Q2

By TrendSpider Editor

Tesla, Inc. is drawing renewed analyst attention on the final trading day of Q1 2026, with two firms reaffirming their existing ratings even as Wall Street's consensus price target of $222.43 sits well below the current trading price of $373.12. Canaccord Genuity is holding its buy rating but trimme

TSLA Stock: Analysts Confirm Split Outlook as Tesla Surges 5% to Start Q2

Tesla, Inc. is drawing renewed analyst attention on the final trading day of Q1 2026, with two firms reaffirming their existing ratings even as Wall Street's consensus price target of $222.43 sits well below the current trading price of $373.12. Canaccord Genuity is holding its buy rating but trimmed its price target to $420 from $520, while GLJ Research is standing firm on its sell rating with a $24.86 target. With TSLA up 5.02% today and trading toward the upper half of its 52-week range of $214.25 to $498.82, the gap between the bulls and the bears could not be wider.

Key Drivers of the TSLA Stock Move

• Main Catalyst: Two analyst confirmations headlined the session. Canaccord Genuity analyst George Gianarikas reaffirmed a buy rating on TSLA while cutting his price target from $520 to $420. GLJ Research analyst Gordon Johnson simultaneously reaffirmed a sell rating with an unchanged price target of $24.86.
• Bull Case: Canaccord's maintained buy rating at a $420 price target implies roughly 12.6% additional upside from today's close of $373.12. The stock is already posting a 5.02% gain on the session, suggesting the market may be responding positively to the buy-side confirmation despite the target reduction.
• Bear Case: GLJ Research's $24.86 price target represents a potential downside of more than 93% from current levels, a stark warning for investors. Meanwhile, the consensus average price target across all tracked analysts sits at $222.43, which is nearly 40% below where shares are trading today, raising questions about whether the recent rally is outpacing fundamental support.

Today's analyst activity arrives at a notable inflection point for Tesla as the calendar flips to Q2 2026. The confirmation from Canaccord signals that at least some institutional voices continue to see a credible path higher from current levels, even after trimming their target by $100. However, the dramatically low consensus average price target of $222.43 reflects persistent skepticism among a broader group of analysts. With the stock sitting between its 52-week low of $214.25 and high of $498.82, the technical picture is equally contested. Investors will likely be watching for Q1 delivery data, which is typically reported in the first days of April, to provide the next hard catalyst for either side of this debate.

TSLA Analyst Ratings and Price Targets

• Canaccord Genuity (George Gianarikas): Confirms buy rating | Price target reduced to $420 from a prior target of $520
• GLJ Research (Gordon Johnson): Confirms sell rating | Price target unchanged at $24.86

Across the two actions reported today, there were zero upgrades and zero downgrades, meaning both analysts held their existing stances. The average price target across covered analysts currently stands at $222.43, a figure that sits nearly 40% below today's price of $373.12 and underscores how divided the Street remains on Tesla's valuation.

TSLA Seasonality

The final day of Q1 and the opening of Q2 has historically been an active period for Tesla, as the company typically releases quarterly vehicle delivery and production figures in the first few days of April. Delivery reports have frequently served as high-volatility catalysts for TSLA shares in prior years, meaning today's analyst activity may be a preview of a more significant move once those figures are published.

TSLA Relative Performance

TSLA's 5.02% gain on the session is a standout move, particularly heading into the final day of the quarter when many large-cap names see more muted trading as portfolio managers finalize positions. The stock's current price of $373.12 places it comfortably above its 52-week low of $214.25 but meaningfully below the 52-week high of $498.82, suggesting the stock has recovered significant ground from its lows but has not yet reclaimed its peak momentum from earlier in the trailing year.